Your shopping cart is currently empty

Chemerin-9 (149-157) TFA is a peptide located at positions 149-157 of chemerin-9, retaining most of the activity of the full protein. Chemerin-9 acts as a ChemR23/CMKLR1 agonist, preventing atherosclerosis whilst inhibiting NLRP3 inflammasome activation and promoting Aβ microglial clearance. It modulates blood pressure and sympathetic nervous system activity via glutamate receptor-mediated ROS production.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $98 | - | In Stock | |
| 5 mg | $207 | - | In Stock | |
| 10 mg | $369 | - | In Stock | |
| 25 mg | $622 | - | In Stock | |
| 50 mg | $885 | - | In Stock | |
| 100 mg | $1,190 | - | In Stock | |
| 200 mg | $1,630 | - | In Stock |
| Description | Chemerin-9 (149-157) TFA is a peptide located at positions 149-157 of chemerin-9, retaining most of the activity of the full protein. Chemerin-9 acts as a ChemR23/CMKLR1 agonist, preventing atherosclerosis whilst inhibiting NLRP3 inflammasome activation and promoting Aβ microglial clearance. It modulates blood pressure and sympathetic nervous system activity via glutamate receptor-mediated ROS production. |
| In vitro | Methods: Chemerin-9 (149-157) TFA (500nM) was used to treat primary microglia stimulated by Aβ42 oligomers to investigate the effects of Chemerin-9 (149-157) TFA on cellular phagocytic ability and inflammatory response. Results: Chemerin-9 (149-157) TFA enhanced the phagocytic capacity of microglia toward Aβ and suppressed NLRP3 inflammasome activation.[1] |
| In vivo | Methods: Chemerin-9 (149-157) TFA (0.2 mg/kg) was intraperitoneally injected into PDM mice to evaluate the effects of chemerin-9 on blood glucose, insulin resistance (IR), and the expression of GLUT2 and PDX1. Results: Chemerin-9 (149-157) TFA treatment significantly increased serum chemerin levels in PDM mice, upregulated the expression of GLUT2 and PDX1, and improved Vitis vinifera glucose tolerance and IR.[2] |
| Synonyms | 9-Methoxyellipticin, 9-Methoxy-5,11-Dimethyl-6H-Pyrido(4,3-B)Carbazole |
| Molecular Weight | 1177.18 |
| Formula | C56H67F3N10O15 |
| Relative Density. | no data available |
| Sequence | H-Tyr-Phe-Pro-Gly-Gln-Phe-Ala-Phe-Ser-OH |
| Sequence Short | YFPGQFAFS |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||
| Solubility Information | H2O: 8 mg/mL (6.8 mM), Sonication is recommended. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
H2O
| ||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.